A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China

NCT05821855 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-angle Glaucoma
OAG

Interventions

DEVICE: XEN45 Glaucoma Treatment System
PROCEDURE: Trabeculectomy

Sponsor

AbbVie